Small Animal Imaging (In-Vivo) Market

Small Animal Imaging (In-Vivo) Market is Expected to Reach $2.1 Billion, Globally, by 2020

PORTLAND, OREGON, UNITED STATE, March 31, 2022 /EINPresswire.com/ — Small Animal Imaging (In-Vivo) Market report, published by Allied Market Research, forecasts that the global market is expected to garner $2.1 Billion by 2020, registering a CAGR of 9.1% during the forecast period 2014 to 2020. Optical imaging modality is and would continue to be the most preferred imaging technology for clinical research organizations (CROs) through 2020, largely due to high sensitivity, economic pricing and a broad scope of applications. Such factors would eventually push the optical imaging technology segment to contribute about 40% of the global small animal imaging market revenue by 2020.

Geographically, ~67% of the small animal imaging (in-vivo) market share is held by the developed regions, due to heavy investments and affordability of advanced small animal in-vivo imaging devices. North America is the dominant region owing to its adoption of advanced technologies, healthcare awareness and favorable reimbursement policies. The research outcomes in the field of small animal imaging market in North America are the blend of academic and industry efforts supported by government programs and initiatives

Download Sample Report :

Rising number of pre-clinical research, increasing investments by the CROs in the research activities, a growing number of multi-functional pre-clinical imaging and technological advancements, namely combination of high resolution MRI with other imaging modalities are the few factors empowering the global market. Spatial resolution multimodal imaging, Cerenkov Bioluminescence Imaging and real time storage multimodal imaging system collectively contribute to the significance of small animal imaging (in-vivo) systems in the drug development and translational research. These technologies exemplify the recent and unique advancements in the field of diagnostic devices, amplifying the scope of applications in pre-clinical as well as clinical research. However, stringent regulatory impositions coupled with inadequate reimbursement policies would restrain the market growth to a certain extent. However, faster commercialization of cost-efficient devices would ease the negative influence of restraints and fuel the market growth, primarily across the developing regions.

Key Findings of Small Animal Imaging (In-Vivo) Market:

Micro MRI, nuclear imaging, and micro CT modalities collectively accounted for about 52% of the revenue generated in 2013
Optical imaging and micro-MRI technology segments would collectively command over 2/3rdof the market revenue during the forecast period
Cancer cell detection application market segment would grow at a higherrate during the forecast period, owing to the rising prevalence rate of cancer across the world

Technologies have a notable impact on the small animal imaging market and manufacturers with novel technology rights are holding substantial market share. Advent in these novel technologies lead sto launch of new and advance product lines in thesmall animal imaging market. To gain the maximum market share, key leaders of the small animal in-vivo imaging market have adopted acquisition as a strategy, which has proved to be the most successful in this market. Key companies profiled in this report are, Thermo Fisher Scientific, Siemens AG, Mediso Medical Imaging Systems, Life Technologies Corporation, Promega Corporation, Miltenyi Biotech, Bruker Corporation, FujiFilm Holding Corporation, PerkinElmer Inc., and Aspect Imaging Ltd.

Small Animal Imaging (IN-VIVO) Market Segmentation:

The small animal imaging (in-vivo) market is segmented by the technology, applications and geography.

By Technology

Micro-Magnetic Resonance Imaging (Micro-MRI)
Optical Imaging (OI)
Bioluminescence Imaging
Cerenkov Luminescence Imaging
Fluorescence Imaging
Nuclear Imaging
Micro-Positron Emission Tomography (Micro-PET)
Micro-Single Photon Emission Computerized Tomography (Micro-SPECT)
Others
Micro-Ultrasound Imaging
Micro-Computerized Tomography (Micro-CT)

By Applications

Monitoring Drug Treatment Response
Biodistribution Studies
Cancer Cell Detection
Biomarkers
Longitudinal Studies
Epigenetics

For Purchase Enquiry:

Other Trending Reports:

Protein Stability analysis Market

Smart Home Healthcare Market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn